1. Home
  2. VCYT vs MGNI Comparison

VCYT vs MGNI Comparison

Compare VCYT & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • MGNI
  • Stock Information
  • Founded
  • VCYT 2006
  • MGNI 2007
  • Country
  • VCYT United States
  • MGNI United States
  • Employees
  • VCYT N/A
  • MGNI N/A
  • Industry
  • VCYT Medical Specialities
  • MGNI Computer Software: Programming Data Processing
  • Sector
  • VCYT Health Care
  • MGNI Technology
  • Exchange
  • VCYT Nasdaq
  • MGNI Nasdaq
  • Market Cap
  • VCYT 2.9B
  • MGNI 3.1B
  • IPO Year
  • VCYT 2013
  • MGNI N/A
  • Fundamental
  • Price
  • VCYT $48.53
  • MGNI $14.73
  • Analyst Decision
  • VCYT Buy
  • MGNI Strong Buy
  • Analyst Count
  • VCYT 9
  • MGNI 10
  • Target Price
  • VCYT $43.56
  • MGNI $26.80
  • AVG Volume (30 Days)
  • VCYT 1.2M
  • MGNI 3.5M
  • Earning Date
  • VCYT 11-04-2025
  • MGNI 11-05-2025
  • Dividend Yield
  • VCYT N/A
  • MGNI N/A
  • EPS Growth
  • VCYT N/A
  • MGNI 219.02
  • EPS
  • VCYT 0.38
  • MGNI 0.38
  • Revenue
  • VCYT $495,141,000.00
  • MGNI $702,565,000.00
  • Revenue This Year
  • VCYT $14.52
  • MGNI $2.09
  • Revenue Next Year
  • VCYT $9.90
  • MGNI $11.41
  • P/E Ratio
  • VCYT $125.41
  • MGNI $38.67
  • Revenue Growth
  • VCYT 16.41
  • MGNI 6.27
  • 52 Week Low
  • VCYT $22.61
  • MGNI $8.22
  • 52 Week High
  • VCYT $50.71
  • MGNI $26.65
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 71.15
  • MGNI 40.47
  • Support Level
  • VCYT $37.98
  • MGNI $13.08
  • Resistance Level
  • VCYT $50.71
  • MGNI $15.14
  • Average True Range (ATR)
  • VCYT 2.11
  • MGNI 0.74
  • MACD
  • VCYT 0.73
  • MGNI 0.23
  • Stochastic Oscillator
  • VCYT 82.09
  • MGNI 65.63

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About MGNI Magnite Inc.

Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.

Share on Social Networks: